Navigating Market Access With Magnolia: October 22, 2026 Webinar Sign Up

From Evidence to Access: Understanding Payer Decisions and Rethinking Engagement

Thursday, October 22, 2026 | 12:00 – 1:00 PM ET

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*

From Evidence to Access: Understanding Payer Decisions and Rethinking Engagement

Clinical evidence is only one part of the payer decision-making process. Coverage and access decisions may also reflect economic, operational, contracting, and other considerations that shape how pharmaceuticals and medical devices are evaluated.

Join Magnolia Market Access for a discussion on how payers make coverage and access decisions, what influences those decisions, and how manufacturers can better align evidence and engagement with payer needs.

What You’ll Learn

  • How payer organizations evaluate coverage and access decisions across pharmaceuticals and medical devices
  • The evidence, stakeholder perspectives, and other inputs that can influence payer decision-making
  • Approaches to payer engagement that help deliver relevant information to the right decision-makers

Join us to better understand payer decision-making and explore how evidence and engagement can support more informed access discussions.